サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439470

乳房再建 - 世界市場の考察、競合情勢、市場予測（2030年）

Breast Reconstruction - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.33円
乳房再建 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乳房再建の市場規模は、2023年に5億5,450万米ドル、2030年までに8億1,014万米ドルに達し、2024年～2030年の予測期間にCAGRで6.54％の成長が見込まれます。乳がんの有病率の増加、美容・再建手術件数の増加、先進技術を利用した乳房再建製品の発売の急増、高齢化、人種、民族などの要因が乳房再建の需要を促進しており、市場はそれらによってプラス成長を示しています。したがって、乳房再建市場は、2024年～2030年の予測期間に大幅なCAGRでの成長が見込まれます。

乳房再建の市場力学

乳房再建市場の主な促進要因の1つは、世界の乳がんの有病率の増加です。2023年に発表された世界保健機関（WHO）のデータによると、2020年に世界で230万人の女性が乳がんと診断されました。前述の同じ資料によると、2020年末までに、過去5年間に780万人の女性が乳がんと診断され、世界でもっとも一般的な疾患となっています。

さらに、乳房再建市場の成長をもたらすもう1つの主な要因が、世界中での美容整形・再建手術の件数の増加です。例えば、Plastic Surgery Statistics Report（2020）によると、アメリカで2020年に行われた美容整形手術の総数は1,560万件で、そのうち230万件が美容外科手術、1,320万件が低侵襲でした。同じ資料によると、2020年に680万件の再建手術が行われました（2019年から3％増）。さらに2020年、アメリカでは19万3,073件の豊胸手術が行われ、そのうちの84%でシリコンインプラントが使用され、16%で生理食塩水インプラントが使用されました。したがって、美容・再建手術の増加に伴い、乳房再建の需要も増加し、それによって乳房再建市場全体の成長が促進されます。

したがって、上記のすべての要因が一体となって2024年～2030年の予測期間に乳房再建市場の全体的な成長を急伸させる見込みです。

しかし、代替の手術をしない手法の利用可能性や、インプラントを使用した乳房再建の高いコストが、世界の乳房再建市場の成長を妨げる見込みです。

進行中のCOVID-19パンデミックは、COVID-19患者に比べ、がんやその他の疾患に罹患している患者の入院や選択的手術が優先されなかったため、乳房再建の市場に悪影響を及ぼしています。ロックダウン規制、スタッフの不足、マスクやPPEキットの不足は、乳房再建に向けた患者の入院に大きな影響を与えました。しかし、大衆のワクチン接種、ロックダウン規制の緩和、選択的手術の再開、マスク、PPEキット、スタッフの利用可能性により、乳房再建市場は勢いを取り戻し、2024年～2030年の予測期間に成長が見込まれています。

乳房再建市場のセグメント分析

乳房再建市場の製品タイプセグメントでは、乳房インプラントが2023年に大きな収益シェアを占めると予測されます。乳房再建市場の主な成長促進要因は、世界中の女性の、審美的な魅力を高める乳房インプラントへの需要の向上などです。乳房再建手術は胸壁の先天的欠陥や奇形に対処し、また乳房の形状や大きさを変えるために使用されます。さらに、乳房再建手術はまた、乳房切除後に自然な外観の乳房を復元する、または単に胸を大きくするのに役立ち、胸に脂肪組織を多く持っていない人々にとってのよい選択肢であり、胸に体積だけでなくカーブを付加します。

したがって、乳房再建に用いる乳房インプラントに関連する利点が、市場での需要を増加させ、予測期間に乳房再建市場全体の成長を促進します。さらに、乳房再建製品に対する規制当局の承認の増加も市場の成長促進要因となっています。例えば2020年9月、世界有数の乳房美容企業であり、Johnson & Johnson Medical Devicesの子会社であるMentor Worldwide LLCは、米国食品医薬品局（FDA）が22歳以上の女性の豊胸手術用と全年齢の女性の乳房再建用として、MENTOR® MemoryGel BOOSTTM乳房インプラントを承認したと発表しました。

当レポートでは、世界の乳房再建市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 乳房再建市場レポートのイントロダクション

第2章 乳房再建市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 乳房再建市場の主な要因の分析

  • 乳房再建市場の促進要因
    • 乳がんの有病率の増加
    • 美容・再建手術の件数の増加
    • 高齢化、人種、民族などの要因が乳房再建市場を促進
    • 先進技術を利用した乳房再建製品の発売の急増
  • 乳房再建市場の抑制要因と課題
    • 代替の手術をしない手法の利用可能性
    • インプラントを使用した乳房再建の高いコスト
  • 乳房再建市場の機会
    • 3Dプリンティング技術の乳房再建への統合
    • 世界中での乳房手術の件数の増加

第5章 乳房再建市場のポーターのファイブフォース分析

第6章 乳房再建市場に対するCOVID-19の影響分析

第7章 乳房再建市場のレイアウト

  • 製品タイプ別
    • 豊胸手術
    • 乳房エキスパンダー
    • 無細胞真皮マトリクス
  • 形状別
    • ラウンド
    • アナトミカル
  • エンドユーザー別
    • 病院
    • 美容クリニック
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 乳房再建市場：世界の企業シェア分析 - 主要3～5社

第9章 乳房再建市場の企業と製品のプロファイル

  • Mentor Worldwide LLC
  • AbbVie Inc
  • IDEAL IMPLANT INCORPORATED
  • Sebbin
  • GC Aesthetics
  • POLYTECH Health & Aesthetics GmbH
  • Sientra Inc
  • Integra LifeSciences
  • Establishment Labs S.A
  • LABORATOIRES ARION
  • HansBioMed
  • Lattice Medical
  • CEREPLAS
  • AirXpanders
  • PMT Corporation
  • SILIMED
  • Technomed (India) Private Limited
  • Apex Medical Device Design LLC (DefyGravity)
  • Guangzhou Wanhe Plastic Material Co Ltd

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Breast Reconstruction market in Global (2021-2030)
  • Table 4: Breast Reconstruction market in Global by Product Type (2021-2030)
  • Table 5: Breast Reconstruction market in Global by Shape (2021-2030)
  • Table 6: Breast Reconstruction market in Global by End User (2021-2030)
  • Table 7: Breast Reconstruction market in Global by Geography (2021-2030)
  • Table 8: Breast Reconstruction market in North America (2021-2030)
  • Table 9: Breast Reconstruction market in North America by Country (2021-2030)
  • Table 10: Breast Reconstruction market in the US (2021-2030)
  • Table 11: Breast Reconstruction market in Canada (2021-2030)
  • Table 12: Breast Reconstruction market in Mexico (2021-2030)
  • Table 13: Breast Reconstruction market in Europe (2021-2030)
  • Table 14: Breast Reconstruction market in Europe by Country (2021-2030)
  • Table 15: Breast Reconstruction market in France (2021-2030)
  • Table 16: Breast Reconstruction market in Germany (2021-2030)
  • Table 17: Breast Reconstruction market in the United Kingdom (2021-2030)
  • Table 18: Breast Reconstruction market in Italy (2021-2030)
  • Table 19: Breast Reconstruction market in Spain (2021-2030)
  • Table 20: Breast Reconstruction market in Russia (2021-2030)
  • Table 21: Breast Reconstruction market in Rest of Europe (2021-2030)
  • Table 22: Breast Reconstruction market in APAC (2021-2030)
  • Table 23: Breast Reconstruction market in APAC by Country (2021-2030)
  • Table 24: Breast Reconstruction market in China (2021-2030)
  • Table 25: Breast Reconstruction market in Japan (2021-2030)
  • Table 26: Breast Reconstruction market in India (2021-2030)
  • Table 27: Breast Reconstruction market in Australia (2021-2030)
  • Table 28: Breast Reconstruction market in South Korea (2021-2030)
  • Table 29: Breast Reconstruction market in Rest of APAC (2021-2030)
  • Table 30: Breast Reconstruction market in Rest of World (2021-2030)
  • Table 31: Breast Reconstruction market in RoW by Region (2021-2030)
  • Table 32: Breast Reconstruction market in Middle East (2021-2030)
  • Table 33: Breast Reconstruction market in Africa (2021-2030)
  • Table 34: Breast Reconstruction market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Breast Reconstruction market in Global (2021-2030)
  • Figure 4: Breast Reconstruction market in Global by Product Type (2021-2030)
  • Figure 5: Breast Reconstruction market in Global by Shape (2021-2030)
  • Figure 6: Breast Reconstruction market in Global by End User (2021-2030)
  • Figure 7: Breast Reconstruction market in Global by Geography (2021-2030)
  • Figure 8: Breast Reconstruction market in North America (2021-2030)
  • Figure 9: Breast Reconstruction market in North America by Country (2021-2030)
  • Figure 10: Breast Reconstruction market in the US (2021-2030)
  • Figure 11: Breast Reconstruction market in Canada (2021-2030)
  • Figure 12: Breast Reconstruction market in Mexico (2021-2030)
  • Figure 13: Breast Reconstruction market in Europe (2021-2030)
  • Figure 14: Breast Reconstruction market in Europe by Country (2021-2030)
  • Figure 15: Breast Reconstruction market in France (2021-2030)
  • Figure 16: Breast Reconstruction market in Germany (2021-2030)
  • Figure 17: Breast Reconstruction market in the United Kingdom (2021-2030)
  • Figure 18: Breast Reconstruction market in Italy (2021-2030)
  • Figure 19: Breast Reconstruction market in Spain (2021-2030)
  • Figure 20: Breast Reconstruction market in Russia (2021-2030)
  • Figure 21: Breast Reconstruction market in Rest of Europe (2021-2030)
  • Figure 22: Breast Reconstruction market in APAC (2021-2030)
  • Figure 23: Breast Reconstruction market in APAC by Country (2021-2030)
  • Figure 24: Breast Reconstruction market in China (2021-2030)
  • Figure 25: Breast Reconstruction market in Japan (2021-2030)
  • Figure 26: Breast Reconstruction market in India (2021-2030)
  • Figure 27: Breast Reconstruction market in Australia (2021-2030)
  • Figure 28: Breast Reconstruction market in South Korea (2021-2030)
  • Figure 29: Breast Reconstruction market in Rest of APAC (2021-2030)
  • Figure 30: Breast Reconstruction market in Rest of World (2021-2030)
  • Figure 31: Breast Reconstruction market in RoW by Region (2021-2030)
  • Figure 32: Breast Reconstruction market in Middle East (2021-2030)
  • Figure 33: Breast Reconstruction market in Africa (2021-2030)
  • Figure 34: Breast Reconstruction market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0283

Breast Reconstruction Market By Product Type (Breast Implants, Breast Expanders, And Acellular Dermal Matrix), By Shape (Round And Anatomical), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of breast cancer and the increase in the number of cosmetic & reconstructive plastic surgeries

The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030. The breast reconstruction market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drives the breast reconstruction demand. Therefore, the market for breast reconstruction is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Breast Reconstruction Market Dynamics:

One of the main drivers of the breast reconstruction market is the increasing prevalence of breast cancer globally. According to World Health Organization (WHO) data published in the year 2023, 2.3 million women worldwide were diagnosed with breast cancer in 2020. As per the same source mentioned above, by the end of 2020, 7.8 million women were diagnosed with breast cancer in the previous five years, making it the most common disease in the world.

Moreover, another key factor that is responsible for the growth of the breast reconstruction market is the increase in the number of cosmetic & reconstructive surgeries across the globe. For instance, according to the plastic surgery statistics report 2020, in America, there were 15.6 million total cosmetic procedures performed in the year 2020, of which 2.3 million were cosmetic surgical procedures and 13.2 million cosmetic procedures were minimally invasive. As per the same source, 6.8 million reconstructive procedures were performed in the year 2020 (a 3% increase from 2019). Further, in the year 2020, in America, there were 193,073 breast augmentations performed, of which silicone implants were utilized in 84% while saline implants were used in 16%. Therefore, with the increase in cosmetic & reconstructive surgeries, demand for breast reconstruction also increases, thereby driving the breast reconstruction overall market growth.

Therefore, all the factors mentioned above will collectively surge the overall growth of the breast reconstruction market during the forecast period from 2024-2030.

However, availability of the alternative non-surgical methods and the high cost of breast reconstruction using implants will hamper the global breast reconstruction market growth.

The ongoing Coronavirus disease 2019 (COVID-19) pandemic has negatively impacted the market for breast reconstruction as hospital admissions for patients suffering from cancers & other disorders as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks, and PPE kits made a huge impact on patient admissions in hospitals for breast reconstruction. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, the breast reconstruction market has picked momentum and is expected to grow during the forecast period from 2024-2030.

Breast Reconstruction Market Segment Analysis:

Breast Reconstruction Market by Product Type (Breast Implants, Breast Expanders, and Acellular Dermal Matrix), Shape (Round and Anatomical), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the by-product type segment of the breast reconstruction market, breast implants are expected to hold a significant revenue share in the year 2023. The key attributes driving the growth of the breast reconstruction market includes the rising demand of breast implants among the women across the globe as to enhance their aesthetic appeal. Breast reconstructive surgery address congenital defects and deformities of the chest wall, it is also used to change shape as well as size of the breast. Further, breast reconstructive surgery also helps to restore a natural-looking breast following a mastectomy, or simply to enlarge the breasts and it's a good alternative for people who don't have a lot of fatty tissue on breast, and adds volume as well as curves to the breast.

Therefore, the benefits associated with breast implants for breast reconstruction would increase their demand in the market, which will drive the growth of the overall breast reconstruction market during the forecast period. Further, the increase in the regulatory approvals for breast reconstruction products is also driving market growth. For instance, in September 2020, Mentor Worldwide LLC, the world's leading breast aesthetics company and a subsidiary of Johnson & Johnson Medical Devices, announced that the US Food and Drug Administration (FDA) has approved the MENTOR® MemoryGel BOOSTTM breast implant for breast augmentation in women over the age of 22 and for breast reconstruction in women of all ages.

Therefore, such type of development activities in the breast implant segment for breast reconstruction would result in driving the demand for breast reconstruction which in turn would provide a conductive growth for the overall breast reconstruction market during the forecast 2024-2030.

North America is expected to dominate the overall Breast Reconstruction Market:

Among all the regions, North America is expected to dominate the global breast reconstruction market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as aging, race, and ethnicity drive breast reconstruction demand, and the surge in the launch of technologically advanced breast reconstruction products are expected to increase the demand for breast reconstructions in the North America market.

According to the American Cancer Society data published in January 2022, breast cancer rates vary between racial and ethnic groupings in the United States. According to the latest statistics, black women are diagnosed at a younger age (60) than white women (63), and they have a higher death rate. This might be because one in every five black women has triple-negative breast cancer, which is greater than any other racial/ethnic group. As per the source mentioned above, black women have a significant risk of having cancer before the age of 40 years.

Furthermore, the most significant risk factor for breast cancer is age. People's risks of having cancer increase as they grow older. According to the American Cancer Society, data published in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older.

Moreover, according to the Breast Cancer Organization data published in the year 2023, more than 3.8 million women in the United States had a history of breast cancer as of January 2022. As per the aforementioned source, by the end of the year 2022, 2,710 additional instances of invasive breast cancer in men are predicted to be detected.

Additionally, another factor such as the surge in the launch of technologically advanced breast reconstruction products will also drive the breast reconstruction market. For instance, in May 2022, GC Aesthetics Inc., a privately-held medical technology company providing aesthetic solutions, announced the launch of its next-generation breast implants, PERLE(TM). It is a highly innovative line of smooth breast implants that features a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (Emunomic(TM) Breast Tissue Dynamic Gel), and an improved version of the safety measures that have underpinned GCA's long-term excellent safety record.

Therefore, the interplay of the factors mentioned above for breast reconstruction would provide a conducive growth environment for the North American region in the breast reconstruction market.

Breast Reconstruction Market Key Players:

Some of the key market players operating in the breast reconstruction market include Mentor Worldwide LLC, AbbVie Inc, IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra Inc, Integra LifeSciences, Establishment Labs S.A, LABORATOIRES ARION, HansBioMed, Lattice Medical, CEREPLAS, AirXpanders, PMT Corporation, SILIMED, DPS Technology Development Ltd, Technomed (India) Private Limited, Apex Medical Device Design LLC (DefyGravity), Guangzhou Wanhe Plastic Material Co Ltd and among others

Recent Developmental Activities in the Breast Reconstruction:

In September 2020, POLYTECH Health & Aesthetics GmbH, a global pioneer in breast aesthetics, expanded its B-Lite® portfolio, which includes the world's first and only lightweight breast implants. B-Lite® breast implants offer several benefits to women, including faster recovery & less post-operative discomfort, allowing patients to return to their normal routine sooner. B-Lite® with MESMO® fine-texturing surface and B-Lite® with the distinctive Microthane® shell coating are among the new forms and surfaces in the enlarged offering

In August 2020, Sientra, Inc, a diversified global medical aesthetics company, announced the approval from Japan's Pharmaceutical and Medical Device Agency ("PDMA") to market its entire OPUS line of breast implants in Japan.

In November 2019, BellaSano, German additive manufacturing start-up signed a long term agreement with Evonik, a chemical company's RESOMER bioresorbable polymer to create a new breast implant technology. RESOMER will be used in BellaSeno's 3D-printed Senella breast scaffold. The product is intended to be used for breast reconstruction, augmentation, and revision surgery. As it is gradually absorbed by the body and the natural breast tissue replaces it.

Key Takeaways from the Breast Reconstruction Market Report Study:

  • Market size analysis for the current breast reconstruction market (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the breast reconstruction market
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint venture happened for last 3 years
  • Key companies dominating the global breast reconstruction
  • Various opportunities available for the other competitor in the breast reconstruction market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current breast reconstruction market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for breast reconstruction market growth in the coming future?

Target Audience who can be benefited from this Breast Reconstruction Market Report Study

  • Breast reconstruction providers
  • Research organizations and consulting companies
  • Breast reconstruction-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in breast reconstruction
  • Various end-users who want to know more about the breast reconstruction market and latest technological developments in the breast reconstruction

Frequently Asked Questions for Breast Reconstruction:

1. What is Breast Reconstruction?

Breast reconstruction is a surgical procedure that reconstructs the form and appearance of a breast, most often in women who have had breast cancer surgery. The objective is to rebuild a natural-looking breast utilizing autologous tissue, artificial implants, or a mix of both.

2. What is the market for Global Breast Reconstruction?

The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030.

3. What are the drivers for the Global Breast Reconstruction market?

The breast reconstruction market is witnessing positive market growth owing to the factors such as, such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity will also contribute in the growth of breast cancer which drives the breast reconstruction product demand.

4. Who are the key players operating in the Breast Reconstruction market?

Some of the key market players operating in the breast reconstruction market include Mentor Worldwide LLC, AbbVie Inc, IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra Inc, Integra LifeSciences, Establishment Labs S.A, LABORATOIRES ARION, HansBioMed, Lattice Medical, CEREPLAS, AirXpanders, PMT Corporation, SILIMED, DPS Technology Development Ltd, Technomed (India) Private Limited, Apex Medical Device Design LLC (DefyGravity), Guangzhou Wanhe Plastic Material Co Ltd and among others.

5. Which region has the highest share in Breast Reconstruction Market?

North America is expected to dominate the global breast reconstruction market. Factors contributing to the growth are the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drive the breast reconstruction demand, contributes to the growth of the breast reconstruction market in the North America region.

Table of Contents

1.Breast Reconstruction Market Report Introduction

2.Breast Reconstruction Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The US
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Breast Reconstruction Market Key Factors Analysis

  • 4.1. Breast Reconstruction Market Drivers
    • 4.1.1. The Increasing Prevalence of Breast Cancer
    • 4.1.2. The Increase in the Number of Cosmetic & Reconstructive Surgeries
    • 4.1.3. The Factors such as Aging, Race, & Ethnicity Drives the Breast Reconstruction Market
    • 4.1.4. The Surge in the Launch of Technologically Advanced Breast Reconstruction Products
  • 4.2. Breast Reconstruction Market Restraints And Challenges
    • 4.2.1. The Availability of the Alternative Non-Surgical Methods
    • 4.2.2. The High Cost of Breast Reconstruction Using Implants
  • 4.3. Breast Reconstruction Market Opportunities
    • 4.3.1. The Integration of 3D Printing Technology in the Breast Reconstruction
    • 4.3.2. The Increase in Number of Breast Surgeries Worldwide

5. Breast Reconstruction Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Breast Reconstruction Market

7. Breast Reconstruction Market Layout

  • 7.1. By Product Type
    • 7.1.1. Breast Implants
    • 7.1.2. Breast Expanders
    • 7.1.3. Acellular Dermal Matrix
  • 7.2. By Shape
    • 7.2.1. Round
    • 7.2.2. Anatomical
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Cosmetology Clinics
    • 7.3.3. Ambulatory Surgical Centers
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Breast Reconstruction Market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Breast Reconstruction Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.2.6. Russia Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.2.7. Rest of Europe Breast Reconstruction Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.3.3. India Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Breast Reconstruction Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Breast Reconstruction Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Breast Reconstruction Market Size in USD million (2021-2030)

8. Breast Reconstruction market Global Company Share Analysis - Key 3-5 Companies

9. Breast Reconstruction Market Company and Product Profiles

  • 9.1. Mentor Worldwide LLC
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. AbbVie Inc
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. IDEAL IMPLANT INCORPORATED
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Sebbin
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. GC Aesthetics
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. POLYTECH Health & Aesthetics GmbH
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Sientra Inc
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Integra LifeSciences
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Establishment Labs S.A
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. LABORATOIRES ARION
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. HansBioMed
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Lattice Medical
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. CEREPLAS
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. AirXpanders
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. PMT Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. SILIMED
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. DPS Technology Development Ltd
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Technomed (India) Private Limited
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Apex Medical Device Design LLC (DefyGravity)
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Guangzhou Wanhe Plastic Material Co Ltd
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us